</HEAD>
<BODY>

<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr><Td background="http://ncicb.nci.nih.gov/sharedimages/3pix.gif"><img src="http://ncicb.nci.nih.gov/sharedimages/3pix.gif"></td></tr>
 <TR>
   <TD background="http://ncicb.nci.nih.gov/sharedimages/minibanner_bgX.jpg" vAlign="top" width="100%"><A href="http://cancer.gov/"><IMG border="0" src="http://ncicb.nci.nih.gov/sharedimages/minibanner_logo.gif" alt="Cancer.gov"></A></TD>
 </TR> 
</table>

<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td align="center" valign="middle" height="73">
      <table width="100%" border="0" cellspacing="0" cellpadding="0" height="73">
        <tr> 
          <td valign="left" align="center" width="107" height="73"><a href="http://www.cancer.gov/index.html"><img src="http://ncicb.nci.nih.gov/sharedimages/ncilogomed.gif" border="0" alt="National Cancer Institute"></a></td>
<td align="center" valign="middle" background="http://ncicb.nci.nih.gov/NCICB/images/spacer.gif" border="0">&nbsp;</td>          
          <td align="center" valign="middle" width="73" height="73"><a href="http://ncicb.nci.nih.gov"><img src="http://ncicb.nci.nih.gov/NCICB/images/NCICBlogotop.jpg" border="0" alt="NCI Center for Bioinformatics"></a></td>

          <td align="left" valign="middle" width="550" height="73"><img src="http://ncicb.nci.nih.gov/NCICB/images/graphic2.jpg"></td>
          <td align="center" valign="middle" background="http://ncicb.nci.nih.gov/NCICB/images/darkspacer2.gif" width="30%" border="0">&nbsp;</td>
          <td align="center" valign="middle" background="http://ncicb.nci.nih.gov/NCICB/images/darkspacer2.gif" border="0">&nbsp;</td>
        </tr>
      </table>
    </td>
  </tr>
</table>




<CENTER>
<H2 style="FONT-FAMILY: arial,helvetica,verdana,sans-serif" >NCICB Maintenance<br/>caMOD - Cancer Models Database</H2>
<TABLE border="0" cellspacing="0" cellpadding="0" width="100%" height="20%">    
  <tr> 
    <td align="center" valign="top">
                  
     <p style="FONT-FAMILY: arial,helvetica,verdana,sans-serif; font-size:16pt; font-style:italic"><br /><br />
     The site you attempted to access is temporarily unavailable while it's being upgraded.
     Please try again after the 21st of December.<br /> 
     </p>
 
     <p style="font-size:16pt; font-style:italic">
											<TABLE style="FONT-SIZE: 0.7em; COLOR: #000000; FONT-FAMILY: arial,helvetica,verdana,sans-serif" cellspacing="0" cellpadding="0" width="700" summary="" border="0">
												<TBODY>
													<TR>
														<TD valign="top">
															<TABLE height="100%" cellspacing="0" cellpadding="10" width="100%" border="0">
																<TBODY>
																	<TR>
																		<TD>
																			<TABLE style="FONT-SIZE: 0.7em; COLOR: #000000; FONT-FAMILY: arial,helvetica,verdana,sans-serif" height="100%" cellspacing="0" cellpadding="0" width="100%" summary="" border="0">
																				<TBODY>
																					<TR>
																						<TD valign="top">
																							<TABLE cellspacing="0" cellpadding="0" width="100%" border="0">
																								<TBODY>
																									<TR>
																										<TD>
																											<TABLE cellspacing="0" cellpadding="3" width="100%" align="center" summary="" border="0">
																												<TBODY>
																													<TR>
																														<TD style="font-size:16pt; font-style:italic">	What's 
	                                new in the upgraded caMOD?
																														</TD>
																													</TR>
																												</TBODY>
																											</TABLE><BR>
																											<TABLE cellspacing="0" cellpadding="3" width="100%" align="center" summary="" border="0">
																												<TBODY>
																													<tr>
																													    <td colspan="2">
																													        <ul>
																													            <li>
																													            New user interface for easier model submission
																													            </li>
																													            <li>
																													            Numerous new features
																													            </li>
																													            <li>
																													            caMOD 2.0 is now caBIG silver level compliant
																													            </li>    
																													        </ul>
																													    </td>
																													</tr>
																													<tr><td>&nbsp;</td></tr>
																													<tr><td colspan="2" style="font-size:16pt; font-style:italic">Summary of new features</td></tr>
																													<TR>
																														<TD style="BORDER-LEFT: #5c5c5c 1px solid; BORDER-BOTTOM: #5c5c5c 1px solid; BORDER-TOP: #5c5c5c 1px solid; PADDING-LEFT: 1em; FONT-SIZE: 0.7em; FONT-FAMILY: verdana, arial, helvetica, sans-serif; BACKGROUND-COLOR: #cccccc" width="20%">	Added 
	                                Features
																														</TD>
																														<TD style="BORDER-LEFT: #5c5c5c 1px solid; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-BOTTOM: #5c5c5c 1px solid; BORDER-TOP: #5c5c5c 1px solid; PADDING-LEFT: 1em; FONT-SIZE: 0.7em; FONT-FAMILY: verdana, arial, helvetica, sans-serif; BACKGROUND-COLOR: #cccccc" width="80%">	How to use 
	                                the new feature?
																														</TD>
																													</TR>
																													<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Utilization of NCI Thesaurus
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%">	caMOD 2.0 utilizes the vocabulary services of NCI Thesaurus. The mouse anatomy and disease vocabularies have been updated by the Pathology working group of the Mouse Models of Human Cancers Consortium (MMHCC).
																														</TD>
																													</TR>
																													<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Utilization of CSM
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%">	caMOD 2.0 utilizes the Common Security Module (CSM) for user authentication.
																														</TD>
																													</TR>
																													<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Submission - previously entered models
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%">	After the user logs in, his/her previously entered models and models in which he/she is listed as the Principal Investigator are shown.
																														</TD>
																													</TR>
																													<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Submission - Model Characteristics
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%">	The scope of the cancer models database was expanded to include tool mice. Tool mice or tool animals are strains that can be used to generate cancer models and do not normally develop tumors. Tool mice are commonly used to generate conditional knock out animals. 
		Examples for tool strains are Cre-expressing strains or strains that carry one or more floxed alleles.
																														</TD>
																													</TR>
																													<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Submission - Genetic Description
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%"> 
	<ul><li>A field was added to all pages in this part of the application to allow the submitter to enter the MGI (Mouse Genome Informatics) number which will enable the retrieval of additional information from the informatics resources at the Jackson Laboratory.
<li>The Targeted Modification page and the Induced Mutation page allow the user to enter the Gene Entrez ID for the affected gene. This will enable us to provide users with additional information about the gene(s).
<li>The Induced Mutation page contains a field for Gene Entrez ID for the affected gene. If a chemical triggered the mutation, the user has the option to enter the CAS number for the chemical that was used.	<li>A submission page for Spontaneous Mutations was added.
<li>The submission pages for Induced and Spontaneous Mutations contain fields to gather information about the genetic changes that occurred in the models as well as the methods of observation used to detect these changes.	</ul>																											</TD>
																													</TR>
																													
																													
																													
																													
																													<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Submission - Carcinogenic Intervention
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%">
	<ul><li>A page for entering information on Gene Delivery was added to this part of the application. 
	<li>All pages of the Carcinogenic Interventions part were updated to include fields for gender, age at treatment, and administrative route (if applicable). <li>The Chemical / Drug page allows the user to enter the NSC and/or CAS number of the chemical used in this experiment. </ul>
																														</TD>
																													</TR>
																													<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Submission - Publication
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%">
	The user is asked to indicate if the publication is the one in which the model was reported for the first time. Eventually this feature will be used to link to records in the Mouse Tumor Biology Database at the Jackson Laboratory. 
																														</TD>
																													</TR>
																													<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Submission - Histopathology
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%">	
	<ul><li>Users can submit information about clinical markers and their values which are found in or are associated with specific tumor types.
	<li>A field for describing the methods of observation / detection of genetic changes in the tumors was added. 
	<li>Users can enter data generated from other species, in particular humans, in the "Comparative Data" field.</ul>
																														</TD>
																													</TR>
																													<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Submission - Therapeutic Approaches
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%">
	<ul><li>To better identify the drug, users can enter the NSC and the CAS number for the compound.
	<li>More detailed information about the therapy can be archived. The following fields have been added: age at treatment, gender, dosage and administrative route.
	<li>The results of experiments can be described in the biomarker and tumor response fields.</ul>
																														</TD>
																													</TR>
																													<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Submission - Microarray Data
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%">	Micrroarray data are stored in MAGE-compliant caArray application instead of the Gene Expression Data Portal (GEDP).
																														</TD>
																													</TR>
																													<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Submission - Images
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%">		The text field for entering the staining method was replaced by a controlled vocabulary. 

																														</TD>
																													</TR>
																													<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Submission - Xenograft
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%">
	Xenograft models can now be entered in a specifically designated part of the application. The Xenograft page adds the following fields: ATCC number, cell amount and graft type. 
																														</TD>
																													</TR>
																													<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Submission - Model Availability
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%">	Users can now enter information about the availability of the animal model from multiple sources. They can also indicate if the tool strains, used to generate the models, are available from multiple sources. The users can make multiple entries per model.
																														</TD>
																													</TR>
																													<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Administrative
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%">	Users who have been assigned the roles of coordinator, screener, and editor will be presented with a to-do list of tasks when they access the Administrative section, following log in.
																														</TD>
																													</TR>
																													<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Search - Simple Search
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%">
	The simple search was expanded with a keyword search option.
																														</TD>
																													</TR>
<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Search - Advanced Search
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%">	The advanced search now includes a query option for drugs or compounds used in therapeutic experiments, an option to query for models that develop metastases, and a keyword search.
																														</TD>
																													</TR>
<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Search - Search Detail Pages
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%">	
	The therapeutic approaches pages include information about drug screens in yeast and in-vivo, as well as clinical trials.
																														</TD>
																													</TR>
<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Search - Navigation
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%">	
	Only search detail pages that contain data will have active links on the left side menu bar. 
																														</TD>
																													</TR>

<TR>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="20%">Search - Drug Screening 
																														</TD>
																														<TD style="PADDING-LEFT: 0.8em; BORDER-RIGHT: #5c5c5c 1px solid; BORDER-LEFT: #5c5c5c 1px solid; FONT-SIZE: 0.8em; COLOR: #000000; BORDER-BOTTOM: #5c5c5c 1px solid; FONT-FAMILY: arial,helvetica,verdana,sans-serif; BACKGROUND-COLOR: #ffffff" width="80%">	The user can query for results of drug testing in yeast strains, xenograft and allograft mouse models (titled for this purpose as in-vivo models), pre-clinical models, and humans. The tests in yeast and in-vivo models were performed by the Developmental Therapeutics Program of the National Cancer Institute. Information about pre-clinical models is retrieved from caMOD, and human data are retrieved via caBIO from clinical trials. 
																														</TD>
																													</TR>



																												</TBODY>
																											</TABLE><BR>
																										</TD>
																									</TR>
																								</TBODY>
																							</TABLE>
																						</TD>
																					</TR>
																				</TBODY>
																			</TABLE>
																		</TD>
														</TD>
													</TR>
												</TBODY>
											</TABLE>
										</TD>
									</TR>
								</TBODY>
							</TABLE>	<!-- Main Content Ends -->

     </p>
     <p>
     &nbsp;&nbsp;If you have any questions or need assistance, please contact us: 
     <a href="mailto:ncicb@pop.nci.nih.gov">ncicb@pop.nci.nih.gov</a> <br /> 
     </p></td>
   <tr>
</table>
<BR><BR>
Thank you for your patience.
<BR><BR>
</CENTER>

<TABLE width="100%" cellspacing="0" cellpadding="4" border="0" bgcolor="#CCCCFF">
  <tr>
    <td><P align="center"><b>Please send comments and suggestions to <A href="mailto:ncicb@pop.nci.nih.gov">ncicb@pop.nci.nih.gov</A></b>
<img src="http://ncicb.nci.nih.gov/NCICB/images/mailto.gif"> 
| <a href="http://www.hhs.gov/Privacy.html">Privacy Notice</a>
| <a href="http://cancer.gov/accessibility/nci508.htm">Accessibility Information</a>
 </P></td>
  </tr>

<tr>
    <td valign="top" align="center">
<a href="http://www.cancer.gov"><img src="http://ncicb.nci.nih.gov/sharedimages/logo_cancergov.gif" border=0 alt="cancer.gov"></a>
<a href="http://www.nih.gov"><img src="http://ncicb.nci.nih.gov/sharedimages/logo_nih.gif" border=0 alt="nih.gov"></a>
<a href="http://www.dhhs.gov"><img src="http://ncicb.nci.nih.gov/sharedimages/logo_dhhs.gif" border=0 alt="H H S logo - link to U. S. Department of Health and Human Services"  ></a>
<a href="http://firstgov.gov"><img src="http://ncicb.nci.nih.gov/sharedimages/logo_firstgov.gif" border=0 alt="firstgov.gov"></a>
    </td>
 </tr>

</TABLE>



</BODY>
</HTML>
